Ingestible Sensor is a device which is used to measure the vitals like blood pressure, sugar levels and many other things of the patient. These are the emerging rapidly as a critical technology that has an ability to impact health, nutrition and clinical areas. Since the past few years, the use of Ingestible Sensors in Hospitals has increased manifold. Innovations in several types of Ingestible Sensors have revolutionized the market. Ingestible Sensors works when the sensor-enabled pills are taken. The patch on the pill is then able to detect the times at which the Sensor-enabled pill has been taken and record other activities and bodily functions. In case of some sensors, the information recorded is also sent on the mobile of the patient
With the advancement in the sensor technologies and significant investments in the research & development of healthcare industry would propel the ingestible sensor market during the forecast period. Real-time patient monitoring, medication, rising number of chronic diseases and need for more accuracy in performing invasive diagnosis tests are the further influencing factors for the ingestible sensors market growth. The rising intricacies in diagnosing & managing chronic diseases and other biomedical activities have opened-up new avenues for the ingestible sensor. The expansion of ingestible sensors in novel medical applications such as customized drug delivery is also fuelling the growth in the market.
Ingestible Sensor Market is segmented on the basis of various factors, namely: By Sensor-type, By Component, By Vertical and By Geography. By Sensor type, the Ingestible Sensors are segregated into Temperature Sensor, Pressure Sensor, PH sensor, Image Sensor and few others. Various Components that constitute Ingestible Sensors are sensors, software, Wearable Patch/Data Recorder and others. It is distinguished by verticals such as Medical, Sports & Fitness and few others. The Report has been analyzed on the regions like North America, South America, Europe, APAC and Rest of the World. All these regions have been sub-categorized into eminent nations holding robust dynamics for ingestible sensors by thoroughly analysing the applications, respective to each nation.
The overall market has also been presented from the perspective of different geographical locations into standard geographic regions and key economies in the market. Competitive landscape for each of the segments is highlighted and market players are profiled with attributes of company overview, financial overview, business strategies, product portfolio and recent developments.
The market is projected to witness $XXm in 2023 growing from XXm in 2016 with CAGR of XX% during the forecast period. Ingestible Sensors Market was dominated by North America. Due to the dietary changes in residents of America, possibility of gastrointestinal diseases grew; which in turn increased the demand of Ingestible Sensors. Europe comes in at second place. Africa are the fastest growing markets of the Ingestible Sensors. Israel is the major contributor of the Sensor-enabled Pills.
Sample Companies Profiled in this Report are:
- Proteus Digital Health, Inc. (The U.S.),
- CapsoVision, Inc. (The U.S.),
- Medimetrics Personalized Drug Delivery B.V. (Netherlands),
- Olympus Corporation (Japan)